• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Unigene Laboratories Inc

+ Add to Watchlist

UUL:GR

Price not available for UUL:GR

Snapshot for Unigene Laboratories Inc (UUL)

Open: - Day's Range: - Volume: 0
Previous Close: 0.002 52wk Range: - 1-Yr Rtn: -

Stock Chart for UUL

No chart data available.
  • UUL:GR
  • 1M
  • 1Y
0.002
Interactive UUL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UUL

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 95.98
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UUL

No data available

Company Profile & Key Executives for UUL

Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the research, production and delivery of small proteins, referred to as peptides, for medical use. The Company has patented oral and nasal drug delivery technologies that have been shown to deliver medically useful amounts of various peptides into the bloodstream and patented manufacturing technologies.

More Company Profile & Key Executives for UUL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil